Certified Drug Free® Get Your Supplement –Draft
Modern advances in scientific and technological progress and new medical developments have significantly changed the traditional approach to the treatment of many urological diseases, in particular, benign prostatic hyperplasia, which is the most common pathology in men over 50 years of age.
The most sparing way to treat surgical treatment of benign prostatic hyperplasia (BPH, or prostate adenoma) is transurethral resection of the prostate. However, the incidence of such a side effect as erectile dysfunction after this intervention ranges from 5 to 35%.
Due to the increased requirements for the quality of life and the recognition of sexual activity as one of the most important criteria for its assessment, the problem of treating erectile dysfunction today has practically no age restrictions and is even more relevant for men who have undergone surgery on the genitals. Thus, although the majority of patients with prostate adenoma who have undergone resection are over 55 years old, therapy to restore erection is relevant for them. It should be noted that transurethral resection of the prostate, although it is a much more gentle operation than radical prostatectomy or transvesical adenomectomy, nevertheless almost always leads to the aggravation of erection problems that already occurred before surgery.
The main cause of problems with potency after any surgical interventions on the pelvic organs is damage to the nerve fibers of the pelvic plexus; also, after transurethral interventions, the nerves of the cavernous bodies and vessels of the penis can be affected.
The average age of patients is 65 years, most of them are in the first or second marriage. At the same time, there are usually about 90% of men interested in maintaining or even improving their erectile function, even if a significant number of them have already had complaints about the sexual sphere, expressed to one degree or another. It should be noted that the lack of awareness of the general population about the features of transurethral methods of treatment of BPH almost 50% of patients are afraid of this intervention because of the fear of completely losing erectile function.
Approximately 35% of patients after transurethral prostatectomy require additional therapy for erectile dysfunction. For this purpose, as a rule, PDE-5 inhibitors are prescribed: Levitra, Viagra or Cialis, and Cialis is the drug of choice, since it can be used with the least risks for the cardiovascular system for a long period (e.g., from 3 to 6 months) on a daily basis. In recent years, since Cialis generics have become available, men who have undergone minimally invasive operations to remove prostate adenoma often prefer generics, since they can be bought at significantly lower prices than the original medicine. In addition, modern Cialis generics, especially Indian ones, tend to cause fewer side effects, which is extremely important when taking the medicine regularly. After 3 months of therapy, almost 80% of men notice a significant improvement in erectile function.
